Exploring a novel drug treatment for osteosarcoma
Drug repurposing targeting immunomodulatory Haem oxygenase-1 (HO-1) for prevention of osteosarcoma growth and metastasis
Drug repurposing targeting immunomodulatory Haem oxygenase-1 (HO-1) for prevention of osteosarcoma growth and metastasis
Dissecting the role of CD133/PROM1 in MLL rearranged acute lymphoblastic leukaemia to develop novel targeted therapy
Investigating the preclinical efficacy of albendazole in paediatric acute myeloid leukaemia
Identifying drivers of central nervous system involvement in T-cell acute lymphoblastic leukaemia
Enhancing CAR T-cell expansion and prolonged persistence for the effective treatment of paediatric medulloblastoma
ALLTogether1 CSF-FLOW Study
Understanding treatment decision-making processes in families where a child or young person has relapsed/refractory rhabdomyosarcoma
MG-fnRMS and CINSARC gene expression signatures to predict relapse in fusion gene negative rhabdomyosarcomas: assessing an approach to improve patient outcomes
Deciphering the genomic landscape of childhood refractory t-cell acute lymphoblastic leukaemia
The treatment your child has will depend on the type of cancer they have.